Joseph Palumbo
Direttore Tecnico/Scientifico/R&S presso BIOVIE INC.
Patrimonio netto: 3 388 $ in data 31/05/2024
Posizioni attive di Joseph Palumbo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOVIE INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2021 | - |
| HYDREIGHT TECHNOLOGIES INC. | Direttore/Membro del Consiglio | 25/11/2022 | - |
Storia della carriera di Joseph Palumbo
Precedenti posizioni note di Joseph Palumbo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/07/2019 | 01/10/2021 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
| MITSUBISHI TANABE PHARMA CORPORATION | Corporate Officer/Principal | - | - |
Formazione di Joseph Palumbo
| University of Pennsylvania Graduate School of Education | Undergraduate Degree |
| George Washington University School of Medicine & Health | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Giappone | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
| Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| BIOVIE INC. | Health Technology |
| HYDREIGHT TECHNOLOGIES INC. | Retail Trade |
| Aziende private | 1 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
- Borsa valori
- Insiders
- Joseph Palumbo
- Esperienza
